Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data-Reference-Cited by-同舟云学术

Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data

Published:2018-05-30 Issue:9 Volume:34 Page:1627-1634
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Kohsaka Shun¹,Katada Jun²,Saito Kumiko³,Terayama Yasuo⁴

Affiliation:

1. Department of Cardiology, Keio University School of Medicine, Tokyo, Japan;

2. Pfizer Japan Inc., Tokyo, Japan;

3. Bristol-Myers Squibb K.K., Tokyo, Japan;

4. Department of Gerontology, School of Medicine, Iwate Medical University, Iwate, Japan

Funder

Bristol-Myers Squibb Co. and Pfizer Inc

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1478282

Reference20 articles.

1. Apixaban versus Warfarin in Patients with Atrial Fibrillation

2. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

3. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

4. Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation

5. Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study;American Journal of Cardiovascular Drugs;2023-10-17

2. Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis;Cureus;2022-08-09

3. Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-06-30

4. Comparative Safety and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation　― A Retrospective Chart Review Study ―;Circulation Journal;2022-01-25

5. Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study;Frontiers in Pharmacology;2021-12-07